Capital Fund Management (CFM)’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Capital Fund Management (CFM)’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-17,314	Closed	-$1.77M	–	1997
2019 Q2	$1.77M	Sell	17,314 -400	-2%	-$43.2K	0.02%	836
2019 Q1	$2.02M	Sell	17,714 -6,093	-26%	-$448K	0.02%	808
2018 Q4	$932K	Buy	+23,807	New	+$1.03M	0.01%	1121
2018 Q3	–	Sell	-15,379	Closed	-$1.27M	–	2412
2018 Q2	$1.27M	Buy	15,379 +1,152	+8%	+$88.9K	0.01%	1248
2018 Q1	$947K	Buy	+14,227	New	+$822K	0.01%	1258
2016 Q3	–	Sell	-6,800	Closed	-$348K	–	1877
2016 Q2	$348K	Buy	+6,800	New	+$291K	﹤0.01%	1282

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Capital Fund Management (CFM)'s ONCE Position: Q3 2019 in Review

Capital Fund Management (CFM) sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 17,314 shares — an estimated $1.77M sold.

Capital Fund Management (CFM) first reported a position in ONCE in Q2 2016 and held it in 6 quarters. The position peaked at $2.02M in Q1 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

Capital Fund Management (CFM) reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Capital Fund Management (CFM) sold 17,314 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $1.77M.
Capital Fund Management (CFM) first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2016 and held it in 6 quarters.
Capital Fund Management (CFM)'s Spark Therapeutics, Inc. Common Stock position peaked at $2.02M in Q1 2019.
184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2019, filed 13 Nov 2019.